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Introduction
Lead (Pb) is a well-known widely distributed environmen-
tal pollutant that can disturb a wide range of biochemical and
physiological functions in humans and laboratory animals’
bodies, its massive environmental accumulation is strongly re-
lated to industrialization and its wide spread usage in gasoline
and paints (Courtois et al., 2003). Lead degradation does not
occur which facilitate its accumulation in water, atmosphere,
food and in organisms living in the polluted environment (Ma-
halley, 1977). High levels of Pb can damage most of the body
organs but mainly central nervous system, kidneys, liver and
bone marrow (Abdel Moneim et al., 2011; Abdel-Moneim et
al., 2011). Lead intoxication pathogenesis may include oxida-
tive cellular damage through generation of highly reactive
oxygen species (ROS) like hydrogen peroxide, hydroxyl radical
and superoxide radical which may result in lipid peroxidation,
systematic depletion of the cellular intrinsic antioxidant de-
fenses power and DNA damage (Ercal et al., 1996; Gurer and
Ercal, 2000; Patra et al., 2011). Oxidative-mediated lead
nephrotoxicity has been proved to occur in several experimen-
tal trials and in environmentally exposed humans (Khalil-
Manesh et al., 1992; El-Sokkary et al., 2005; Lin et al., 2006;
Wang et al., 2010b) as kidney is one of the most favorable tar-
get organs for lead toxicity (Smith et al., 1998). Impaired kid-
ney functions have been proved as one of the most reliable
features of lead toxicity (Chang et al., 1980) which was  char-
acterized by an increase in serum concentration of urea and
creatinine (Missoun et al., 2010; Wang et al., 2013) with an el-
evation in urinary activity of several kidney damage related
enzymes including alkaline phosphatase, gamma-glutamil-
transpeptidase and N-acetyl-β-d-glucosaminidase in addition
to increased urinary protein content (proteinuria) including
microalbumin and β2-microgobulin (Wang et al., 2010a). An-
tioxidants are protective agents that deactivate reactive oxy-
gen species which can delay or prevent oxidative damage;
they include cellular naturally synthesized antioxidant as su-
peroxide dismutase, catalase and glutathione peroxidase be-
sides dietary antioxidants (Halliwell, 1994). The role of dietary
antioxidants as carotenoids, vitamin C, vitamin E and polyphe-
nols has received much attention in last few years (Halliwell et
al., 1995; Sies and Stahl, 1995).
Lycopene is a carotenoid that is mainly present in tomato,
processed tomato and some other fruits, among dietary
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Presumptive Ameliorative Effect of Lycopene on Lead-induced Nephro-
toxicity in Males Wistar Rats
Dina R.S. Gad El-Karim*
Lycopene is a natural carotenoid that has been reported to exhibit excellent antioxidant and anti-in-
flammatory activities. In this study, male Wistar albino rats received lead (Pb) (300 mg/L, in drinking
water) and/or lycopene (4mg/kg) for 8 consecutive weeks to investigate the ameliorative effect of ly-
copene upon Pb-induced nephrotoxicity. Renal damage was assessed by detecting serum level of urea,
creatinine, acute kidney injury molecule-1and cystatin-C, in addition, serum level of some inflammatory
cytokines were assessed. Also, renal lipid peroxide level and antioxidant status of the kidney with renal
activity of energy metabolism enzymes (pyruvate kinase (PK) and glucose-6-phosphatase (G-6-P) were
evaluated. Moreover, lead-induced nephrotoxicity was evaluated via light microscopy examination of
renal tissues. Animals that received lycopene and Pb together showed enhanced kidney functions and
minimal pathological alteration than Pb-treated rats. Moreover, lycopene administration significantly
decreased serum level of inflammatory cytokines and boosted redox balance of the kidney. Furthermore,
renal activity of PK and G-6-P enzymes was increased significantly upon administration of lycopene
with Pb.  In conclusion, this study elucidated the inhibitory effect of lead toxicity on renal glucose meta-
bolic enzymes and declared that lycopene can ameliorate Pb-induced renal damage through its an-
tioxidant and anti-inflammatory properties. 
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carotenoids, lycopene is considered as one of the most potent
antioxidants (Rao and Agarwal, 1999; Rao and Agarwal, 2000).
Lycopene bioactive metabolites (lycopenoids) are thought to
be responsible for most of the mechanisms of action of ly-
copene in prevention of chronic diseases risk, which noticed
with the consumption of high lycopene-containing foods
(Lindshield et al., 2007). Several studies have been proved the
powerful antioxidant activity of lycopene against nephrotoxi-
city caused by ROS (Atessahin et al., 2005; Yilmaz et al., 2006;
Augusti et al., 2007; Ateşşahin et al., 2007). This study aimed
to investigate some biochemical changes related to lead
nephrotoxicity and the probable ameliorative role of lycopene
against these alterations.
Materials and methods
Experimental animals
Twenty-eight male Wistar albino rats about 6-8 weeks’ old
were purchased from laboratory animal unit of Pharos Univer-
sity, Alexandria, Egypt were used to perform this study. They
were housed in metal cages and left to acclimatize for two
weeks. They were exposed to 12-hours/12-hours light/dark
cycle, ambient temperature and humidity. They had a free ac-
cess to commercial standard pellets diet and drinking water.
This work was approved by Institutional Animal Care and Use
Committee (IACUC), Alexandria University, Egypt.
Experimental protocol 
At the end of the adaptation period, the animals were al-
located randomly into four equal groups (n=7) as follow: I-
Control: containing rats received distilled water as drinking
water and 1ml of corn oil by gastric gavage, II- Lycopene-
treated group: received an oral dose of lycopene extract (4
mg/kg b.wt.) (Atessahin et al., 2005) in form of standardized
10% powder (KAN Phytochemical,  India)  in corn oil by gastric
intubation, III-Lead-treated group: received lead acetate
(Alpha-Chem, India) at a dose level of 300mg/L (Wang et al.,
2010b) in drinking water, IV- Lead-lycopene-treated group:
which received lead and lycopene at identical doses and
routes of groups II and III. All the treatments continued daily
for 8 consecutive weeks.
Collection of blood samples and tissues
Twenty-four hours after the end of the experimental pe-
riod and last treatment and under the effect of light ether
anesthesia, blood samples were drawn from retro-orbital ve-
nous plexus into plain tubes for separation of serum by cen-
trifugation at 1000 × g for 10 minutes. Then, the animals were
euthanized using an excessive dose of ether followed by cer-
vical dislocation, both of the two kidneys were removed,
washed in normal saline solution and one of them was kept
in 10% neutral buffered formalin solution for histopathological
examination and the other was frozen at -80°C for preparation
of the homogenate. Kidney homogenate was prepared by cut-
ting of the kidney into small pieces using surgical scalpel,
washing several times by phosphate buffer saline (PBS) to re-
move any blood, addition of PBS to the tissues (9:1 volume)
and homogenization at 4°C (Glass-Col® tissue homogenizer,
China). The resultant homogenate aliquots were centrifuged
at 10000 × g for 4°C for 10 minutes; supernatant was sepa-
rated and kept at -80°C for subsequent detection of oxidant-
antioxidant biomarkers and glucose metabolic enzymes.
Protein content of the homogenate was assessed using Brad-
ford's reagent (Sigma-Aldrich, USA).
Assessment of serum renal toxicity biomarkers
Serum level of urea and creatinine were determined using
commercially available kits (Diamond, Egypt), serum level of
cystatin-C and acute kidney injury molecule-1(AKIM-1) were
detected using rat specific sensitive immune-reactive ELISA
kits (INOVA Biotech, China; Crystal Chem, USA).
Assessment of serum pro-inflammatory cytokines
The levels of tumor necrosis factor-alpha (TNF-α), inter-
leukin-6 (IL-6) and interleukin-1beta (IL-1β) were assessed in
serum of the animals of different treated groups using highly
specific ELISA kits (Abcam, USA).
Assessment of some oxidative stress biomarkers
Renal tissues level of malondialdehyde (MDA) and glu-
tathione (GSH) with renal activity of catalase (CAT) were de-
tected using commercially available kits (Biodiagnostic, Egypt). 
Biochemical assessment of pyruvate kinase enzyme activity
Renal activity of pyruvate kinase enzyme was assessed
using pyruvate kinase (PK) assay kit (Abcam, USA) which de-
pends on presence of phosphoenolpyruvate, which is cat-
alyzed by PK enzyme into pyruvate and ATP, the generated
pyruvate is then oxidized by pyruvate oxidase to give color;
the increase in color intensity is proportional to the increase
in pyruvate content which reflect the activity of PK enzyme.
Biochemical assessment of glucose-6-phosphatase enzyme ac-
tivity
The activity of renal glucose-6-phosphatase enzyme (G-
6-p) was assessed according to Swanson (1955), depending
on the amount of inorganic phosphate liberated from glu-
cose-6-phosphat as substrate for the enzyme using Tausky
Shorr reagent. The assay chemicals were obtained from
Sigma-Aldrich, USA.
Histopathological examination
Formalin preserved kidney specimen of each rat was
processed through paraffin embedding technique (Bancroft
and Stevens, 1996), sectioned at 5 microns and stained with
Mayer’s haematoxylin and eosin (H&E). The stained sections
were examined under light microscope and photographed
using Nikon® digital camera.
Semi-quantitative histopathological scoring system
Simple semi-quantitative scoring for the renal histopatho-
logical lesions was performed for different treated groups. In
conclusion, five fields (×100) were selected in a random man-
ner from each rat in each group, and the most obvious patho-
logical lesions were selected for the scoring; the severity of
each lesion was graded based on the percentage of affected
area/entire section as follow: 0 = absence of lesion, 1 = 5–
25%, 2 = 26–50%, and 3 = ≥50%.
Statistical Analysis
Different experimental groups values were compared
using one-ways analysis of variance (ANOVA) followed by
Duncan's test using the SPSS statistical package v22.0 for Win-
dows (IBM, Armonk, NY, USA). All data were presented as
mean± SD and P< 0.05 was marked significant.
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Results
Serum level of some nephrotoxic biomarkers
Serum concentration of urea, creatinine, cystatin-C and
AKIM-1 of lead-intoxicated rats were significantly higher
(P<0.05) when compared to control group. Combined admin-
istration of lycopene with lead to the rats significantly ame-
liorated the elevation in serum concentration of these
nephrotoxic biomarkers in comparison with lead-intoxicated
rats. No significant changes could be noticed in the serum
level of any of the previously listed parameters in the rats of
lycopene-treated group as compared with control group
(Table 1).
Serum pro-inflammatory cytokines
The level of TNF-α, IL-6 and IL-1β in serum of lead-intox-
icated rats recorded a significant elevation (P<0.05) when
compared to control group animals; fortunately, co-adminis-
tration of lycopene with lead significantly lowered the serum
level of these pro-inflammatory cytokines. As compared to
control group, administration of lycopene as a sole treatment
significantly decreased serum concentration of these pro-in-
flammatory cytokines (Table 1).
Renal oxidant/anti-oxidant levels
In comparison with the control group, renal concentration
of lipid peroxide (MDA) recorded a significant increase
(P<0.05) in lead-intoxicated rats, which was accompanied by
a significant decrement in renal tissues content of GSH and
activity of CAT and SOD enzymes. Co-treatment of lead-intox-
icated rats with lycopene significantly lowered the concentra-
tion of MDA in renal tissues and also, increased these tissues
content of GSH and enhanced the activity of CAT and SOD en-
zymes when compared to the respective lead-intoxicated
group values. Sole treatment with lycopene significantly de-
creased the level of renal MDA, increased renal GSH content
and enhanced the activity of CAT and SOD enzymes in renal
tissues, if compared to the control group (Table 2).
Activity of PK and G6P in renal tissues
In comparison with the control group, the activity of PK
and G6P enzymes in kidneys of lead-intoxicated rats were sig-
nificantly lower (P<0.05) than control values. The activity of
these enzymes was significantly increased in renal tissues of
rats upon administration of lycopene with lead as compared
to lead-intoxicated group. Administration of lycopene to the
rats alone did not reveal any significant changes in the activity
of these enzymes when compared to the control group (Table
2).
Histopathological results
Histopathological examination of kidneys of control and
lycopene-treated animals did not reveal any histopathological
changes in renal tissues details or architectures. While, kidneys
of lead-intoxicated group showed glomerular atrophy and
broadening of glomerular space (Fig.1a) with presence of ex-
tended area of tubular necrosis infiltrated with inflammatory
cells (Fig.1b), in addition to interstitial fibrosis (Fig.1c) and se-
vere renal perivascular inflammatory cells infiltration (Fig.1d).
On the other hand, lead+lycopene-treated group showed
mild renal tubular necrosis (Fig.1e) besides the presence of
previously described lesion but in less severe degree and dis-
tribution. Table 3 illustrated the results of semi-quantitative
scoring of severity and distribution of the detected lesions in
different treated groups.
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Table 1. The effect of different treatments on serum renal biomarkers and some pro-inflammatory cytokines.
Groups
Control Lycopene Lead Lead + Lycopene
Urea (mg/dl) 26.20±2.39c 25.50±1.95c 53.60±4.81a 42.20±2.27b
Creatinine (mg/dl) 0.38±0.02c 0.37±0.02c 0.86±0.03a 0.61±0.04b
Cystatin-C ((mg/L) 1.13±0.08c 1.08±0.07c 3.57±0.10a 2.08±0.05b
AKIM-1 (ng/ml) 25.40±2.50c 23.60±2.16c 62.00±3.76a 41.60±2.56b
TNF-α (pg/ml) 21.70±4.01c 19.60±3.70d 116.10±10.74a 66.90±6.28b
IL-6 (pg/ml) 172.80±13.76c 165.60±13.72d 717.80±39.41a 446.00±52.62b
IL-1β (pg/ml) 45.90±7.41c 42.80±7.18d 223.00±16.30a 121.20±11.33b
Table 2. The effect of different treatments on renal oxidative biomarkers and some renal glucose-related metabolic enzymes. 
All the values are expressed as mean ±SD. Means within the same raw of different litters are significantly different at (P < 0.05). MDA: Malon-
dialdehyde; GSH: Glutathione; CAT: Catalase; SOD: Superoxide dismutase; PK: Pyruvate kinase; G-6-P: glucose-6-phosphatase
All the values are expressed as mean ±SD. -Means within the same row of different litters are significantly different at (P < 0.05). AKIM-1: acute
kidney injury molecule-1; TNF-α: Tumor necrosis factor-alpha; IL-6: interleukin-6; IL-1β: interleukin-1beta
Groups
Control Lycopene Lead Lead + Lycopene
MDA (nmol/mg protein) 2.80±0.24c 1.98±0.09d 6.62±0.34a 4.12±0.24b
GSH (mmol/mg protein) 19.10±1.35b 21.16±1.01a 10.12±0.78d 14.28±0.60c
CAT (U/ mg protein) 13.44±1.14b 14.36±1.18a 6.06±0.76d 9.20±0.66c
SOD (U/ mg protein) 3.38±0.21b 4.00±0.16a 2.08±0.19d 2.66±0.20c
PK (mU/ mg protein) 2.01±0.05a 2.10±0.05a 1.14±0.07c 1.65±0.06b
G-6-P (U/ mg protein) 1.65±0.06a 1.66±0.08a 0.84±0.06c 1.15±0.06b
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Discussion
Lead is a common industrial and environmental heavy
metal or pollutant that has been proved to be present in all
phases of environment and biological systems. The accumu-
lation of lead in the animals and human bodies and its related
health risk became an issue of current debate and interest (Ju-
berg et al., 1997). Liver, Kidney and brain are the main target
organs for lead to express its toxic effect (Sharma and Street,
1980), which depends on ROS generation (Patra et al., 2001)
but, the maximum accumulation of this biotoxicant is reported
in the kidneys upon chronic exposure (Humphreys, 1991). So,
this study aimed to evaluate the protective effect of lycopene
(as a natural dietary antioxidant) against lead-induced
nephrotoxicity.
Lead-related nephrotoxicity is mainly associated with lipid
peroxide formation due to ROS generation, which affects mi-
tochondrial functions causing its damage and a subsequent
cellular death (Wang et al., 2010a; Sen et al., 2006). The previ-
ously explained mechanism may demonstrate the significant
increase in serum concentration of urea and creatinine of Pb-
intoxicated rats which indicated the decrease in glomerular fil-
tration rate (due to glomerular damage) of these animals as a
consequence of Pb intoxication (Jayakumaret al., 2009; Wang
et al., 2010b; Wang et al., 2013). Combined with these findings,
the concentration of serum cystatin-C was significantly in-
creased in Pb-intoxicated rats and this may affirm the nephro-
toxic effect of lead as cystatin-C is a non-glycosylated protein,
which is fully catabolized by renal tubules after filtration with-
Dina R.S. Gad El-Karim /Journal of Advanced Veterinary Research 9 (3) (2019) 91-96
Fig. 1. Photomicrograph of rat kidney section stained with H&E of lead group (a,b,c,d) showing shrunken glomeruli with widening of glomerular
space (arrow) and congestion of interstitial blood vessel (arrow head) (a) (×400), wide area of renal tubular necrosis with mononuclear inflam-
matory cells infilteration (star)  (b) (×200), renal tubular necrosis (A) and fibrosis (asterisk) (c) (×400) with wide spread perivascular mononuclar
inflammatory cells infilteration (A) (d) (×200) and a section in a rat kidney of lead+lycopene group showing minimal renal tubular necrosis (A)
(e) (×400).
Table 3. The score of detected renal lesions in male Wistar albino rats of different experimental groups
Scored lesions
Incidence1 and Severity2 of histopathological Lesions
Lead-intoxicated rats Lead+ Lycopene-treated rats
Absent
(-)
Mild
(+)
Moderate
(++)
Severe
(+++)
Absent
(-)
Mild
(+)
Moderate
(++)
Severe 
(+++)
1-Glomerular atrophy 0 1 6 0 2 4 1 0
2-Tubular necrosis 0 0 3 4 0 4 2 1
3-Congested capillaries (cortical
or medullary) 0 1 4 2 0 6 1 0
4-Interstitial fibrosis 0 2 3 2 5 2 0 0
5-Perivascular and interstitial
mononuclear cells  infiltration 0 0 1 6 3 2 2 0
1Number of rats with lesions per total examined (7 rats).
2Severity of lesions was graded by estimating the percentage area affected in the entire section. 
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out any reabsorption, so it is considered as a more accurate
marker of renal filtration power (Murty et al., 2013). In parallel,
AKIM-1 is a transmembrane protein, which is highly upregu-
lated in tubular epithelium after kidney injury, shed into tu-
bular lumen and reabsorbed to reach blood, so it is one of the
most accurate blood biomarker for tubular injury (Sabbisetti
et al., 2014) and this may demonstrate its significant elevation
in serum of Pb-intoxicated group. The elevation in the previ-
ously discussed nephrotoxic biomarkers effectively proved
both of glomerular and tubular injuries caused by lead intox-
ication. 
Oxidative stress evoked by lead intoxication was declared
in this study by the significant increase in renal tissues con-
centration of lipid peroxide (MDA), which coupled with signif-
icant depletion of enzymatic antioxidants (GSH, SOD and CAT)
(Patra et al., 2001; Sivaprasad et al., 2002; Wang et al., 2010b;
Wang et al., 2013). Lycopene is one of the most powerful an-
tioxidant among different known carotenoids (Hazewindus et
al., 2012) and this could be a reason for the potential role of
lycopene in partial recovery of biochemical and oxidant-an-
tioxidant alteration related to lead peroxidative nephrotoxicity,
particularly by reducing oxidative stress in renal tissues as
recorded by several studies (Ateşşahin et al., 2005; Ateşşahin
et al., 2007).
Experimental and clinical trials have indicated that the in-
flammatory process mediated by innate immune responses
plays a crucial role in the development and progression of lead
nephrotoxicity as the levels of the pro-inflammatory cytokines
specially, TNF-α, IL-6, and IL-1β were increased in renal tissues
of lead-intoxicated rats (Liu et al., 2012; Salama et al., 2016).
In the present study, the increment in serum level of these pro-
inflammatory cytokines was mitigated upon lycopene treat-
ment which suggests that lycopene has an important
implication in anti-inflammatory reaction (Di Mascio et al.,
1989; Bignotto et al., 2012; Hadad and Levy, 2012).
Pyruvate kinase enzyme is the master enzyme controlling
glycolysis in most of the body tissues as it catalyzes the final
step of glycolysis to yield ATP (Gupta and Bamezi, 2010). Find-
ings from this study declared that PK enzyme activity in renal
tissues of lead-intoxicated rats was significantly decreased
which may have a role in occurrence of renal cellular death
due to energy deprivation in case of lead intoxication. The rea-
son may be that PK contains a sulfhydryl group, which is im-
portant for its properties and catalytic activity (Tomich and
Colman, 1985; Rafter and Blair, 1987) and unfortunately, lead
is known as an inhibitor for sulfhydryl containing enzymes
(Vallee and Ulmer, 1972; Gurer et al., 1999) including PK en-
zyme (Yun and Hoyer, 2000; Lepper et al., 2010). On the other
hand, G-6-P enzyme can liberate glucose from glucose-6-
phosphate upon cellular need, but it was detected that the
destruction of microsomal G-6-P enzyme may occur as a result
of exposure to lipid peroxide (Hruszkewycz et al., 1978; Daniels
et al., 1995) and this may explain the decrease in renal activity
of this enzyme in lead intoxicated animals (due to lead-related
oxidative stress). Fortunately, the previously affirmed antioxi-
dant effect of lycopene may assist in amelioration of PK en-
zymes inhibition through reservation of renal GSH level as
GSH has a great role as a chelator for heavy metals including
lead (Reed, 1990; Meister, 1994) decreasing its effect on thiol
containing enzymes as PK. In addition, lycopene may alleviate
the destruction of G-6-P enzyme via relieving of lead-induced
oxidative stress (ROS generation) and its resultant lipid per-
oxide which inhibit G-6-P enzyme. Histopathologically, lead-
related oxidative nephrotoxicity is characterized by glomerular
sclerosis, proximal tubular nephropathy and interstitial fibrosis
(Loghman-Adham, 1997; Diamond, 2004) and this came in a
total accordance with our results concerning histopathological
evaluation of lead intoxicated rat's kidneys, also, the
histopathological findings confirmed the obtained biochemi-
cal results and the ameliorative role of lycopene against lead-
induced nephrotoxicity. 
Conclusion
This study illuminated the inhibitory effect of lead intox-
ication-related oxidative stress on PK and G-6-P enzymes in
renal tissues as a co-factor for occurrence of renal cellular in-
jury and proved the attenuative role of lycopene as an antiox-
idant and anti-inflammatory substance in mitigation of
lead-related nephrotoxicity. 
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